• About
    • What We Do
    • Leadership Team
    • Board of Directors
  • Pipeline
    • Overview
    • Obesity
    • IBIO-101
  • Platform
  • Partnering
  • Media/Events
    • Events
    • Press Releases
    • In the News
    • Presentations
  • Careers
  • Investors
  • Contact
Investors

Press Releases

Investors

Investors

  • Overview
  • Company Info
    • Profile
    • Management Team
    • Presentations
  • News & Events
    • Press Releases
    • IR Calendar
  • Stock Data
    • Quote
    • Historical Data
  • SEC Filings
  • Annual Shareholder Reports
  • Corporate Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Resources
    • IR Contact
    • Email Alerts
    • Investor FAQ
  • News & Events

  • Press Releases
  • IR Calendar
Jun 26, 2020 6:45am EDT

iBio to be Added to the Russell 2000® and Russell 3000® Indexes

Jun 24, 2020 6:45am EDT

iBio Selected by IBM Watson Health for the use of IBM Clinical Development Solution at No Cost to help Support clinical COVID-19 Vaccine Candidates

Jun 04, 2020 7:00am EDT

iBio Announces Second COVID-19 Vaccine Program

Apr 27, 2020 4:15pm EDT

iBio Estimates ~500 Million Dose Capacity for COVID-19 Vaccine from its FastPharming Facility™

Apr 09, 2020 7:30am EDT

iBio Expands COVID-19 Vaccine Collaboration to Include the Infectious Disease Research Institute

Mar 26, 2020 4:20pm EDT

iBio Supporting AzarGen Biotechnologies’ Development of a Rituximab Biosimilar

Mar 26, 2020 7:30am EDT

iBio Announces Advancement of COVID-19 Vaccine Program

Mar 20, 2020 7:30am EDT

iBio Joins the Alliance for Biosecurity

Mar 18, 2020 8:00am EDT

iBio Announces Development of Proprietary COVID-19 Vaccine Candidates

Mar 12, 2020 4:45pm EDT

iBio Announces Leadership Succession, Appoints Thomas F. Isett Co-Chairman & CEO

  • Previous
  • 1…
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • …20
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
  • About
  • Pipeline
  • Platform
  • Media/Events
  • Careers
  • Investors
  • Contact

Headquarters

11750 Sorrento Valley Road
Suite 200
San Diego, CA 92121

(979) 446-0027
LinkedIn
info@ibioinc.com
RSS News Feed
© 2023 iBio, Inc. All Rights Reserved.
PRIVACY POLICY AND TERMS OF USE.